Paresthesia Treatment Market By Disease Type (Acute Paresthesia, Chronic Paresthesia), By Treatment (Immunosuppressant, Anticonvulsants, Topical Creams, Antivirals, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global paresthesia treatment market was valued at $5,376.28 million in 2021, and is projected to reach $7,900.0 million by 2031, registering a CAGR of 3.8% from 2022 to 2031.
Paresthesia is numbness and a burning feeling that occurs most often in the extremities, such as the hands, arms, legs, or feet. It can occur elsewhere in the body as well. It is the same “pins and needles” feeling that happens when someone sits on their leg or foot for too long. It is caused when the nerves of arms and legs are under any kind of pressure. The discomfort goes away, once that pressure is relieved. Some people may have chronic paresthesia, which could be a sign of a more serious nerve injury or condition. Some of the causes of paresthesia include stroke, multiple sclerosis, tumor in the spinal cord or brain, high levels of vitamin D or other vitamins, diabetes, fibromyalgia, high blood pressure, infection, nerve injury, and compressed or pinched nerve. The symptoms of paresthesia include tingling or a “pins and needles” sensation, aching or burning pain, numbness or poor feeling in the affected area, a feeling that the affected area has “fallen asleep”, prickling or itching feeling, and hot or cold skin.
The global paresthesia treatment market is anticipated to show significant market growth during the forecast period, owing to rise in the prevalence of disease such as cancer, surge in geriatric population, and lack of proper nutrients in the food. Furthermore, increase in prevalence of paresthesia among the population, poor lifestyle, and surge in healthcare expenditure considerably contribute toward the market growth. However, low effectiveness of medicines associated with the treatment and stringent regulatory rules of the authority for the approvals of the medicines negatively impact the market growth. Conversely, the surge in investments in the research and developments (R&Ds) for better treatment offers lucrative opportunities for the growth of the market.
The paresthesia treatment market is segmented on the basis of disease type, treatment, distribution channel, and region. By disease type, the market is bifurcated into acute paresthesia and chronic paresthesia. Furthermore, the acute paresthesia is sub-classified as pediatric and adult. The chronic paresthesia segment is sub-classified as pediatric and adult. By treatment, the market is fragmented into immunosuppressant, anticonvulsants, topical creams, antivirals, and others. By distribution channel, the market is divided into hospital pharmacy, retail pharmacy, and online pharmacy. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, Taiwan and Rest of Asia-Pacific), and LAMEA (Brazil, Turkey, Venezuela, South Africa, Saudi Arabia, and Rest of LAMEA).
The major companies profiled in the report include Abbott Laboratories, AbbVie Inc., Baxter International Inc., Bio-Medical Research Ltd., Boston Scientific Corporation, Cipla Ltd., Cyberonics, Inc., GlaxoSmithKline plc., Glenmark Pharmaceuticals, Medtronic plc, Merck KGaA, NeuroBo Pharmaceuticals, Inc., Nevro Corporation, Omron Healthcare, Inc. , Pfizer Inc., Reshape Lifesciences Inc., and Stimwave, LLC.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the paresthesia treatment market analysis from 2021 to 2031 to identify the prevailing paresthesia treatment market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the paresthesia treatment market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global paresthesia treatment market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Disease Type
Acute Paresthesia
Age Group
Adult
Geriatric
Chronic Paresthesia
Age Group
Adult
Geriatric
By Treatment
Immunosuppressant
Anticonvulsants
Topical Creams
Antivirals
Others
By Distribution Channel
Online Pharmacy
Hospital Pharmacy
Retail Pharmacy
By Region
North America
U.S.
Canada
Mexico
Europe
Spain
Rest of Europe
France
Germany
UK
Italy
Asia-Pacific
Japan
China
India
Australia
South Korea
Taiwan
Rest Of Asia Pacific
LAMEA
Brazil
Turkey
Venezuela
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Abbott Laboratories
AbbVie Inc.
Baxter International Inc.
Bio-Medical Research Ltd.
Boston Scientific Corporation
Cipla Ltd.
Cyberonics, Inc.
EnteroMedics Inc.
GlaxoSmithKline plc.
Glenmark
Medtronic
Merck
Nevro Corp.
Omron Healthcare, Inc.
Pfizer
Stimwave LLC
Stryker Corp.
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook